CYP2C19 and major depressive disorder: The present study aims to assess the association between CYP2C19 SSRI inferred metaboliser status based on individual CYP2C19 polymorphisms and patient-reported efficacy of sertraline, citalopram and escitalopram in the Australian Genetics of Depression Study (AGDS).